MycoBiomDB – Record Details (MyCo_2498)

Biomarker Record Details

Database ID: MyCo_2498
DB IDMyCo_2498
TitleEpidemiological characteristics of patients with invasive pulmonary aspergillosis infected with Aspergillus fumigatus from a tertiary hospital in Ningxia, China
Year2025
PMID40234690
Fungal Diseases involvedInvasive pulmonary aspergillosis
Associated Medical ConditionNone
GenusAspergillus
Speciesfumigatus
OrganismAspergillus fumigatus
Ethical StatementDue to the retrospective nature of this study, informed consent was waived by the Medical Science Ethics Committee of General Hospital of Ningxia Medical University.
Site of InfectionNone
Opportunistic invasiveInvasive
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameGM
Biomarker Full NameGalactomannan
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationChina
CohortA retrospective analysis was conducted on the medical records of 249 inpatients diagnosed with “Aspergillus fumigatus colonization or infection” at Ningxia Medical University General Hospital from January 2018 to December 2023.
Cohort No.249
Age Group21-91
P Valuep<0.001
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismInvasive pulmonary aspergillosis (IPA) is a severe fungal infection primarily affecting immunocompromised individuals, such as those with hematologic malignancies, organ transplant recipients, and patients undergoing prolonged corticosteroid therapy. The disease is caused by Aspergillus species, with Aspergillus fumigatus being the most common pathogen.
TechniqueELISA
Analysis MethodELISA Based
ELISA kitsELISA Kit- Platelia Aspergillus (Platelia™ Aspergillus Ag, Bio-Rad Laboratories, Hercules, CA, USA)
Assay DataNone
Validation Techniques usedFDA Approved -Platelia Aspergillus ELISA
Up Regulation Down RegulationIncrease
Sequence DataNone
External LinkNone